Rocket Pharmaceuticals Files 8-K on Shareholder Votes
Ticker: RCKTW · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1281895
| Field | Detail |
|---|---|
| Company | Rocket Pharmaceuticals, Inc. (RCKTW) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
Rocket Pharma is asking shareholders to vote on stuff. Details TBD.
AI Summary
Rocket Pharmaceuticals, Inc. filed an 8-K on June 18, 2025, to report on the submission of matters to a vote of its security holders. The filing indicates that the company is seeking approval for certain corporate actions from its shareholders. Further details regarding the specific proposals or resolutions are not provided in this excerpt.
Why It Matters
This filing signals that Rocket Pharmaceuticals is engaging its shareholders in key corporate decisions, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — This is a routine procedural filing regarding shareholder votes, not indicating any immediate financial or operational risks.
Key Players & Entities
- Rocket Pharmaceuticals, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-36829 (file_number) — SEC File Number
- 9 Cedarbrook Drive Cranbury , NJ 08512 (address) — Principal Executive Offices
FAQ
What specific matters are being submitted for a vote of security holders?
The provided excerpt does not specify the exact matters being submitted for a vote. It only states that the 8-K filing is for the 'Submission of Matters to a Vote of Security Holders'.
When was the earliest event reported in this filing?
The earliest event reported in this filing is June 18, 2025, which is also the date of the report.
What is the company's state of incorporation?
Rocket Pharmaceuticals, Inc. is incorporated in Delaware.
What is the company's principal executive office address?
The principal executive offices are located at 9 Cedarbrook Drive, Cranbury, NJ 08512.
What is the SEC file number for Rocket Pharmaceuticals, Inc.?
The SEC file number for Rocket Pharmaceuticals, Inc. is 001-36829.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding ROCKET PHARMACEUTICALS, INC. (RCKTW).